ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe
Go back to ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.74 +0.07 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.67 | 52 Week High | $45.58 | |||
| Open | $50.79 | 52 Week Low | $37.82 | |||
| Day High | $51.18 | P/E | N/A | |||
| Day Low | $50.59 | EPS | $0.00 | |||
| Volume | 3,735,158 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.74 +0.07 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.67 | 52 Week High | $45.58 | |||
| Open | $50.79 | 52 Week Low | $37.82 | |||
| Day High | $51.18 | P/E | N/A | |||
| Day Low | $50.59 | EPS | $0.00 | |||
| Volume | 3,735,158 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.08 -0.13 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.20 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 41,061,133 | |||||
